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The Relationship between Osteogenesis Imperfecta and Spinal Muscular Atrophy
Abstract
Objective
A 4-month-old female with osteogenesis imperfecta (OI) type II was admitted in 
PICU of our center due to severe respiratory distress and fever with a diagnosis 
of severe pneumonia, and mechanical ventilation was initiated. Due to severe 
hypotonia, NCV and EMG were performed, and spinal muscular atrophy (SMA) 
type I was diagnosed.
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Case report 
The patient was a 4-month-old female with osteogenesis imperfecta type II (OI) due to 
fracture of both femurs at birth. She was put on biphosphonate therapy (pamidronate). The 
subject was born through repeat caesarean section and was the second child of the family. 
Her sister was a healthy 3-year-old girl with no history of osteoporosis or fracture. Her 
parents were first degree relatives. The patient was admitted to our center’s PICU with 
severe respiratory distress due to pneumonia; thus, mechanical ventilation was initiated. 
She was alert with severe hypotonia in the frog-leg position with bluish sclera (Fig-1-
3). There was a depressed occipital fracture, probably due to birth trauma. There was 
consolidation and collapse of the right middle and lower lung lobes. A pneumothorax 
developed 2 days after admission, which improved with a chest tube. The affected lung 
expanded with the appropriate antibiotics, chest physiotherapy, and suctioning of the 
secretions. Due to severe hypotonia and the NCV and EMG findings, SMA type I was 
diagnosed. The patient was ventilator-dependent and did not tolerate extubation.
Discussion
Osteogenesis imperfecta (OI), a secondary cause of osteoporosis, manifests principally 
as bone fragility that affects up to 1 per 10,000 (1,2). OI results from mutations in genes 
encoding for type I collagen (3). Type I collagen fibers are composed of a left-handed 
helix, formed by the intertwining of pro-alpha1 and pro-alpha2 chains. Mutations in 
the loci encoding these chains (COL1A1 on band 17q21 andCOL1A2 on band 7q22.1, 
respectively) cause OI. Mutant expression produces nonfunctional collagen (severe OI) 
or insufficient quantities of collagen (mild OI). There are 7 subtypes of OI, varying in 
severity, age of presentation, and clinical features (4-7). Biphosphonates have been shown 
to increase bone mass, decrease fracture rates, and relieve symptoms of OI patients (8).
SMA is the second most frequent autosomal recessive disease in Caucasians, with an 
incidence of 1 per 6000 to 10,000 live births  and carrier rate between 1 in 34 to 50. 
SMA type I (Werdnig-Hoffmann disease), the most common and severe form, usually 
1.Assistant Professor, Pediatric 
Infectious Diseases, Faculty of 
Medicine, Kashan University of 
Medical Sciences,Kashan, Iran
2.Professor of Pediatric Infectious 
Diseases,Faculty of Medicine,Shahid 
Beheshti University of Medical 
Sciences, Tehran, Iran
3. Associate Professor of Pediatric 
Infectious Diseases,Faculty of 
Medicine,Shahid Beheshti University 
of Medical Sciences, Tehran, Iran
4. BS of Nursery, Head Nurse of 









How to Cite this Article: Soltani B, Karimi A, Fahimzad A, Talebian M. The Relationship between Osteogenesis Imperfecta and Spinal Muscular Atrophy. Iranian 
Journal of Child Neurology 2011;5(3): 37-39.
38 Iran J Child Neurology   Vol5 No3 Summer  2011
The Relationship between Osteogenesis Imperfecta and Spinal Muscular Atrophy
presents within the first 6 months of life. Death, secondary 
to respiratory distress, occurs primarily within the first 18 
months of life. Over 90% of all types of the disease are 
linked to the same region of chromosome 5q (9-11). This 
region contains the survival motor neuron gene, which may 
have areas of inversion, duplication, or deletion (12). SMA 
is classified into 4 major types by the international SMA 
consortium (13). In one study, 3 patients with multiple 
fractures and Werdnig-Hoffmann disease were presented. 
Two of the 3 were erroneously diagnosed as having OI. 
The etiology of these fractures appeared to be in utero 
osteoporosis, secondary to decreased movement that led to 
pathological fractures during birth. Immobilization led to 
uneventful healing in these cases, and no recurrent fractures 
were seen (14). The diagnosis of OI in our patient was made 
clinically; additional fractures did not occur, perhaps due to 
the prescription of pamidronate therapy. Because this patient 
has expired on behalf of his severe respiratory distress, we 
could not find the genetic mutation, on the other hand, we 
could not find any genetic associations between OI and SMA, 
but it is possible that there is an unknown genetic relationship 
between SMA and OI that is not defined for any of the 7 
types of OI. SMA alone can affect fractures at birth due to 
osteoporosis that is caused by intrauterian immobilization. 
In fact, it is not clear whether she has OI with SMA or only 
SMA type I that is complicated by osteoporosis and bone 
fractures.
In conclusion, the diagnosis of osteogenesis imperfecta in 
our patient was made clinically, but additional fractures did 
not occur, which could have been due to the pamidronate. 
These observations need  further studies. Fig 3. Radiographic signs after 2 months (no callus 
formation)
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